KFF Health News' 'What the Health?': Florida Limits Abortion — For Now
The Florida Supreme Court handed down dual abortion rulings this week. One said voters will be allowed to decide in November whether to create a state right to abortion. The other ruling, though, allows a 15-week ban to take effect immediately — before an even more sweeping, six-week ban replaces it in May. Meanwhile, President Joe Biden is doubling down on his administration’s health care accomplishments as he kicks off his general election campaign. Lauren Weber of The Washington Post, Joanne Kenen of the Johns Hopkins University schools of nursing and public health, and Tami Luhby of CNN join KFF Health News’ Julie Rovner to discuss these stories and more. Also this week, Rovner interviews health care analyst Jeff Goldsmith about the growing size and influence of UnitedHealth Group in the wake of the Change Healthcare hack.
Telehealth’s Limits: Battle Over State Lines and Licensing Threatens Patients’ Options
By Julie Appleby
Televisits took off during the worst days of the pandemic, but states are now rolling back the temporary rules that facilitated them. That’s adding fuel to debates about states’ authority over medical licensing.
If the Unvaccinated Want to Work, They Face a Series of Hurdles
By Julie Appleby
As employers create safety protocols for workers who refuse vaccination, we ask experts if they really work. Or is the point to pressure employees into getting a shot?
Journalists Tackle Delta Variant, Hospital Prices and Public Health Spending
By khnalessandrab
KHN and California Healthline staff made the rounds on national and local media this week to discuss their stories. Here’s a collection of their appearances.
Diabetes Drug’s New Weight Loss Formula Fuels Cost-Benefit Debate
By Julie Appleby
Health plans’ coverage of the medication, branded as Wegovy — which has a $1,300-a-month price tag — is not a sure thing.
Journalists’ Topics Range From Rural Pharmacy Deserts to Opioid Overdoses
By khnalessandrab
KHN and California Healthline staff made the rounds on national and local media this week to discuss their stories. Here’s a collection of their appearances.
Facing Headwinds on New Alzheimer’s Drug, Biogen Launches Controversial Campaign
By Julie Appleby
The makers of Aduhelm, a drug approved last month despite concerns raised by experts about its effectiveness, have launched a website and ads designed to urge people who are worried about their memory to ask doctors about testing. But some health advocates say it is misleading because some memory loss with aging is normal.
Una prueba rápida negativa no significa que se está libre de covid
By Julie Appleby and Phil Galewitz
Muchos ven a los kits caseros negativos como una “tarjeta de libertad”. Pero puede haber errores, y también infecciones futuras.
How Not to Use Rapid Covid Tests
By Julie Appleby and Phil Galewitz
Although at-home antigen testing remains a useful tool, experts warn it is often used inappropriately and can provide false confidence for people concerned about safety.
Children and Covid: Journalists Explore Grief and Vaccine Side Effects
KHN and California Healthline staff made the rounds on national and local media this week to discuss their stories. Here’s a collection of their appearances.
